BLTE
Price
$64.96
Change
+$1.93 (+3.06%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
2.07B
77 days until earnings call
ELVN
Price
$20.91
Change
+$0.64 (+3.16%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
1.2B
65 days until earnings call
Interact to see
Advertisement

BLTE vs ELVN

Header iconBLTE vs ELVN Comparison
Open Charts BLTE vs ELVNBanner chart's image
Belite Bio
Price$64.96
Change+$1.93 (+3.06%)
Volume$1.35K
Capitalization2.07B
Enliven Therapeutics
Price$20.91
Change+$0.64 (+3.16%)
Volume$2.84K
Capitalization1.2B
BLTE vs ELVN Comparison Chart in %
Loading...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLTE vs. ELVN commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLTE is a StrongBuy and ELVN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (BLTE: $63.03 vs. ELVN: $20.27)
Brand notoriety: BLTE and ELVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLTE: 31% vs. ELVN: 130%
Market capitalization -- BLTE: $2.07B vs. ELVN: $1.2B
BLTE [@Biotechnology] is valued at $2.07B. ELVN’s [@Biotechnology] market capitalization is $1.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLTE’s FA Score shows that 0 FA rating(s) are green whileELVN’s FA Score has 1 green FA rating(s).

  • BLTE’s FA Score: 0 green, 5 red.
  • ELVN’s FA Score: 1 green, 4 red.
According to our system of comparison, ELVN is a better buy in the long-term than BLTE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLTE’s TA Score shows that 6 TA indicator(s) are bullish while ELVN’s TA Score has 5 bullish TA indicator(s).

  • BLTE’s TA Score: 6 bullish, 5 bearish.
  • ELVN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BLTE is a better buy in the short-term than ELVN.

Price Growth

BLTE (@Biotechnology) experienced а -2.13% price change this week, while ELVN (@Biotechnology) price change was -2.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

BLTE is expected to report earnings on Nov 18, 2025.

ELVN is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLTE($2.07B) has a higher market cap than ELVN($1.2B). BLTE YTD gains are higher at: -0.111 vs. ELVN (-9.911). BLTE has higher annual earnings (EBITDA): -50.43M vs. ELVN (-113.93M). ELVN has more cash in the bank: 491M vs. BLTE (145M). BLTE has less debt than ELVN: BLTE (537K) vs ELVN (580K). BLTE (0) and ELVN (0) have equivalent revenues.
BLTEELVNBLTE / ELVN
Capitalization2.07B1.2B172%
EBITDA-50.43M-113.93M44%
Gain YTD-0.111-9.9111%
P/E RatioN/AN/A-
Revenue00-
Total Cash145M491M30%
Total Debt537K580K93%
TECHNICAL ANALYSIS
Technical Analysis
BLTEELVN
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
84%
Bearish Trend 5 days ago
85%
Momentum
ODDS (%)
Bearish Trend 5 days ago
72%
Bullish Trend 5 days ago
85%
MACD
ODDS (%)
Bearish Trend 5 days ago
75%
Bullish Trend 5 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
78%
Bearish Trend 5 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
76%
Bullish Trend 5 days ago
84%
Advances
ODDS (%)
Bullish Trend 13 days ago
77%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
80%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
71%
Bullish Trend 6 days ago
76%
Aroon
ODDS (%)
Bullish Trend 5 days ago
57%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGEAX34.420.07
+0.20%
Brandes Global Equity A
MVGMX18.450.02
+0.11%
MFS Low Volatility Global Equity R4
PAECX19.59-0.10
-0.51%
Putnam Dynamic Asset Allocation Gr C
MRIBX25.15-0.20
-0.79%
MFS Research International B
GSJPX40.66-0.68
-1.64%
Goldman Sachs Technology Opps P

BLTE and

Correlation & Price change

A.I.dvisor tells us that BLTE and ACOG have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BLTE and ACOG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
-2.29%
ACOG - BLTE
27%
Poorly correlated
+2.98%
FGHQF - BLTE
25%
Poorly correlated
N/A
URGN - BLTE
23%
Poorly correlated
+1.09%
IBIO - BLTE
23%
Poorly correlated
-0.90%
ELVN - BLTE
23%
Poorly correlated
-0.44%
More

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with CRNX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
-0.44%
CRNX - ELVN
51%
Loosely correlated
+1.11%
SYRE - ELVN
50%
Loosely correlated
-1.38%
XNCR - ELVN
49%
Loosely correlated
+0.99%
ZYME - ELVN
48%
Loosely correlated
-0.20%
ERAS - ELVN
48%
Loosely correlated
N/A
More